GENI.STGENI.STSTO
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+13.9%
5Y CAGR+21.3%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+13.9%/yr
vs +29.2%/yr prior
5Y CAGR
+21.3%/yr
Recent deceleration
Acceleration
-15.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$39.58M+11.4%
2024$35.52M+17.8%
2023$30.16M+12.7%
2022$26.75M+10.7%
2021$24.16M+60.2%
2020$15.08M+19.6%
2019$12.61M+31.4%
2018$9.60M+69.3%
2017$5.67M-11.6%
2016$6.41M-